Product Wiki · Recalls · U.S. FDA — Device Enforcement

Recall Z-0491-2025 — Abbott Navitor Titan, Vision Technology, Transcatheter Aortic Heart Valve, 35 mm, NVRO-35, Sterile

U.S. FDA — Device Enforcement · United States · 2024-10-17 · Class II

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
Agency
U.S. FDA — Device Enforcement
Recall identifier
Z-0491-2025
Date of alert
2024-10-17
Country / jurisdiction
United States
Risk level
Class II
Risk type
recall
Brand
Abbott Medical
Product category
device
Product type
Devices
Barcode (EAN/GTIN)
05415067045768
Reported risk: A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.
Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.